brello glp 1 pricing Review: GLP-1 Access & Clinical Fit – PlexusDx Ro vs Brello: GLP-1 Telehealth
Description
Medical necessity typically requires documented obesity (BMI 30) plus at least one weight-related comorbidity such as type 2 diabetes, hypertension, sleep apnea, nonalcoholic fatty liver disease, or cardiovascular disease
They specialize in midlife women's care, combining hormone therapy and weight loss support in one place
Food and Drug Administration (FDA) approved an oral GLP-1 formulation called Rybelsus (semaglutide) for the treatment of type 2 diabetes
If you're considering moving forward, work through these steps in order
They were also approved in 2021 by the US Food and Drug Administration for weight loss for patients who are overweight or obese and have at least one comorbid condition
